Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001557746-16-000002
Filing Date
2016-06-14
Accepted
2016-06-14 12:10:44
Documents
1
Effectiveness Date
2016-06-14
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13894
  Complete submission text file 0001557746-16-000002.txt   15007
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-264946 | Film No.: 161712409
SIC: 2834 Pharmaceutical Preparations